<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-pharmaceutics-13-00387">
 <label>58.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>AEMPS</collab>
  </person-group>
  <article-title>CIMA</article-title>
  <source>Ficha Técnica Azitromicina Sandoz 200 mg/5 mL Polvo para Suspensión Oral EFG.</source>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://cima.aemps.es/cima/dochtml/ft/71180/FT_71180.html#6-datos-farmac-uticos" xmlns:xlink="http://www.w3.org/1999/xlink">https://cima.aemps.es/cima/dochtml/ft/71180/FT_71180.html#6-datos-farmac-uticos</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-07-01">(accessed on 1 July 2020)</date-in-citation>
 </element-citation>
</ref>
